A portfolio of biologic self-injection devices in rheumatology: how patient involvement in device design can improve treatment experience

References

• Abramson A, Caffarel-Salvador E, Khang M, et al. (2019). An ingestible self-orienting system for oral delivery of macromolecules. Science 363:611–5.
   PubMed Web of Science ®Google Scholar
• Bessette L, Lebovic G, Millson B, et al. (2018). Impact of the adalimumab patient support program on clinical outcomes in ankylosing spondylitis: results from the COMPANION study. Rheumatol Ther 5:75–85.
   PubMed Web of Science ®Google Scholar
• Bhol KC, Tracey DE, Lemos BR, et al. (2013). AVX-470: a novel oral anti-TNF antibody with therapeutic potential in inflammatory bowel disease. Inflamm Bowel Dis 19:2273–81.
   PubMed Web of Science ®Google Scholar
• Bluett J, Morgan C, Thurston L, et al. (2015). Impact of inadequate adherence on response to subcutaneously administered anti-tumour necrosis factor drugs: results from the Biologics in Rheumatoid Arthritis Genetics and Genomics Study Syndicate cohort. Rheumatology (Oxford) 54:494–9.
   PubMed Web of Science ®Google Scholar
• Borrás-Blasco J, Gracia-Perez A, Castera MD, et al. (2013). Educational session as a tool to increase patient satisfaction of switching etanercept from the prefilled syringe to the autoinjection pen. Expert Opin Biol Ther 13:1103–8.
   PubMed Web of Science ®Google Scholar
• Bugni VM, Ozaki LS, Okamoto KY, et al. (2012). Factors associated with adherence to treatment in children and adolescents with chronic rheumatic diseases. J Pediatr (Rio J) 88:483–8.
   PubMed Web of Science ®Google Scholar
• Calloway A, Dalal R, Beaulieu DB, et al. (2017). Depressive symptoms predict anti-tumor necrosis factor therapy noncompliance in patients with inflammatory bowel disease. Dig Dis Sci 62:3563–7.
   PubMed Web of Science ®Google Scholar
• Collier DH, Bitman B, Coles A, et al. (2017). A novel electromechanical autoinjector, AutoTouch, for self-injection of etanercept: real-world use and benefits. Postgrad Med 129:118–25.
   PubMed Web of Science ®Google Scholar
• Coorey GM, Neubeck L, Mulley J, et al. (2018). Effectiveness, acceptability and usefulness of mobile applications for cardiovascular disease self-management: Systematic review with meta-synthesis of quantitative and qualitative data. Eur J Prev Cardiol 25:505–21.
   PubMed Web of Science ®Google Scholar
• Cox D, Mohr DC. (2003). Managing difficulties with adherence to injectable medications due to blood, injection, and injury phobia and self-injection anxiety. American Journal of Drug Delivery 1:215–21.
   Google Scholar
• Cross MJ, March LM, Lapsley HM, et al. (2006). Patient self-efficacy and health locus of control: relationships with health status and arthritis-related expenditure. Rheumatology (Oxford) 45:92–6.
   PubMed Web of Science ®Google Scholar
• Domańska B, Mountian I, Vinconneau G. (2017a). Patient-preferred design features of TNF inhibitor self-injection devices: insights from a rheumatoid arthritis auto-injector preference study. Value in Health 20:A591–2.
   Web of Science ®Google Scholar
• Domańska B, Stumpp O, Poon S, et al. (2018). Using patient feedback to optimize the design of a certolizumab pegol electromechanical self-injection device: insights from human factors studies. Adv Ther 35:100–15.
   PubMed Web of Science ®Google Scholar
• Domańska B, VanLunen B, Peterson L, et al. (2017b). Comparative usability study for a certolizumab pegol autoinjection device in patients with rheumatoid arthritis. Expert Opin Drug Deliv 14:15–22.
   PubMed Web of Science ®Google Scholar
• Elliott RA. (2008). Poor adherence to medication in adults with rheumatoid arthritis. Disease Management & Health Outcomes 16:13–29.
   Google Scholar
• EMA, (2018). Summary of product characteristics: benepali. https://www.ema.europa.eu/documents/product-information/benepali-epar-product-information_en.pdf
   Google Scholar
• FDA, (2016a). Applying human factors and usability engineering to medical devices: guidance for industry and Food and Drug Administration staff. https://www.fda.gov/downloads/MedicalDevices/…/UCM259760.pdf.
   Google Scholar
• FDA, (2016b). Human factors studies and related clinical study considerations in combination product design and development: draft guidance for industry and FDA staff. https://www.fda.gov/downloads/RegulatoryInformation/Guidances/UCM484345.pdf.
   Google Scholar
• Feldman SR. (2013). Disease burden and treatment adherence in psoriasis patients. Cutis 92:258–63.
   PubMed Web of Science ®Google Scholar
• Fidder HH, Singendonk MM, van der Have M, et al. (2013). Low rates of adherence for tumor necrosis factor-alpha inhibitors in Crohn's disease and rheumatoid arthritis: results of a systematic review. World J Gastroenterol 19:4344–50.
   PubMed Web of Science ®Google Scholar
• Finckh A, Escher M, Liang MH, et al. (2016). Preventive Treatments for Rheumatoid Arthritis: Issues Regarding Patient Preferences. Curr Rheumatol Rep 18:51.
   PubMed Web of Science ®Google Scholar
• Fortune DG, Richards HL, Kirby B, et al. (2002). A cognitive-behavioural symptom management programme as an adjunct in psoriasis therapy. Br J Dermatol 146:458–65.
   PubMed Web of Science ®Google Scholar
• Fraenkel L, Bogardus ST, Concato J, et al. (2004). Patient preferences for treatment of rheumatoid arthritis. Ann Rheum Dis 63:1372–8.
   PubMed Web of Science ®Google Scholar
• French-Mowat E, Burnett J. (2012). How are medical devices regulated in the European Union? Journal of the Royal Society of Medicine 105:S22–S28.
   PubMedGoogle Scholar
• Freundlich B, Kivitz A, Jaffe JS. (2014). Nearly pain-free self-administration of subcutaneous methotrexate with an autoinjector: results of a phase 2 clinical trial in patients with rheumatoid arthritis who have functional limitations. J Clin Rheumatol 20:256–60.
   PubMed Web of Science ®Google Scholar
• Gadallah MA, Boulos DN, Gebrel A, et al. (2015). Assessment of rheumatoid arthritis patients' adherence to treatment. Am J Med Sci 349:151–6.
   PubMed Web of Science ®Google Scholar
• Galo JS, Mehat P, Rai SK, et al. (2016). What are the effects of medication adherence interventions in rheumatic diseases: a systematic review. Ann Rheum Dis 75:667–73.
   PubMed Web of Science ®Google Scholar
• Ganguli A, Clewell J, Shillington AC. (2016). The impact of patient support programs on adherence, clinical, humanistic, and economic patient outcomes: a targeted systematic review. Patient Prefer Adherence 10:711–25.
   PubMed Web of Science ®Google Scholar
• Gau M, Takasawa K. (2017). Initial patient choice of a growth hormone device improves child and adolescent adherence to and therapeutic effects of growth hormone replacement therapy. J Pediatr Endocrinol Metab 30:989–93.
   PubMed Web of Science ®Google Scholar
• Gossec L, Guyard F, Leroy D, et al. (2018). Detection of flares by decrease in physical activity, collected using wearable activity trackers, in rheumatoid arthritis or axial spondyloarthritis: an application of Machine-Learning analyses in rheumatology. Arthritis Care Res (Hoboken). doi:https://doi.org/10.1002/acr.23768.
   Google Scholar
• Greiner P, Sawka A, Imison E. (2015). Patient and physician perspectives on MSdialog, an electronic PRO diary in multiple sclerosis. Patient 8:541–50.
   PubMedGoogle Scholar
• Harrison M, Marra C, Shojania K, et al. (2015). Societal preferences for rheumatoid arthritis treatments: evidence from a discrete choice experiment. Rheumatology (Oxford) 54:1816–25.
   PubMed Web of Science ®Google Scholar
• Hibbard JH, Stockard J, Mahoney ER, et al. (2004). Development of the Patient Activation Measure (PAM): conceptualizing and measuring activation in patients and consumers. Health Serv Res 39:1005–26.
   PubMed Web of Science ®Google Scholar
• Hider SL, Tanveer W, Brownfield A, et al. (2009). Depression in RA patients treated with anti-TNF is common and under-recognized in the rheumatology clinic. Rheumatology (Oxford) 48:1152–4.
   PubMed Web of Science ®Google Scholar
• Hill J, Bird H, Johnson S. (2001). Effect of patient education on adherence to drug treatment for rheumatoid arthritis: a randomised controlled trial. Ann Rheum Dis 60:869–75.
   PubMed Web of Science ®Google Scholar
• Homer D, Nightingale P, Jobanputra P. (2009). Providing patients with information about disease-modifying anti-rheumatic drugs: individually or in groups? A pilot randomized controlled trial comparing adherence and satisfaction. Musculoskeletal Care 7:78–92.
   PubMedGoogle Scholar
• Horne R, Chapman SC, Parham R, et al. (2013). Understanding patients' adherence-related beliefs about medicines prescribed for long-term conditions: a meta-analytic review of the Necessity-Concerns Framework. PLoS One 8:e80633.
   PubMed Web of Science ®Google Scholar
• Horne R, Weinman J, Hankins M. (1999). The beliefs about medicines questionnaire: the development and evaluation of a new method for assessing the cognitive representation of medication. Psychology & Health 14:1–24.
   Web of Science ®Google Scholar
• Jiang F, Jiang Y, Zhi H, et al. (2017). Artificial intelligence in healthcare: past, present and future. Stroke Vasc Neurol 2:230–43.
   PubMedGoogle Scholar
• Joplin S, van der Zwan R, Joshua F, et al. (2015). Medication adherence in patients with rheumatoid arthritis: the effect of patient education, health literacy, and musculoskeletal ultrasound. Biomed Res Int 2015:150658.
   PubMed Web of Science ®Google Scholar
• Jørgensen TS, Skougaard M, Taylor PC, et al. (2018). The Parker Model: applying a qualitative three-step approach to optimally utilize input from stakeholders when introducing new device technologies in the management of chronic rheumatic diseases. Patient 11:515–26.
   PubMedGoogle Scholar
• Karter AJ, Subramanian U, Saha C, et al. (2010). Barriers to insulin initiation: the translating research into action for diabetes insulin starts project. Diabetes Care 33:733–5.
   PubMed Web of Science ®Google Scholar
• Keininger D, Coteur G. (2011). Assessment of self-injection experience in patients with rheumatoid arthritis: psychometric validation of the Self-Injection Assessment Questionnaire (SIAQ). Health Qual Life Outcomes 9:2.
   PubMed Web of Science ®Google Scholar
• Kivitz A, Cohen S, Dowd JE, et al. (2006). Clinical assessment of pain, tolerability, and preference of an autoinjection pen versus a prefilled syringe for patient self-administration of the fully human, monoclonal antibody adalimumab: the TOUCH trial. Clin Ther 28:1619–29.
   PubMed Web of Science ®Google Scholar
• Kivitz A, Segurado OG. (2007). HUMIRA pen: a novel autoinjection device for subcutaneous injection of the fully human monoclonal antibody adalimumab. Expert Rev Med Devices 4:109–16.
   PubMed Web of Science ®Google Scholar
• Lange J, Richard P, Bradley N. (2014). Usability of devices for self-injection: results of a formative study on a new disposable pen injector. Med Devices (Auckl) 7:195–203.
   PubMedGoogle Scholar
• Lange J, Richard P, Bradley N. (2015). Usability of a new disposable autoinjector platform device: results of a formative study conducted with a broad user population. Med Devices (Auckl) 8:255–64.
   PubMedGoogle Scholar
• Lezcano-Valverde JM, Salazar F, León L, et al. (2017). Development and validation of a multivariate predictive model for rheumatoid arthritis mortality using a machine learning approach. Scientific Reports 7:10189.
   PubMed Web of Science ®Google Scholar
• Lopez-Gonzalez R, Leon L, Loza E, et al. (2015). Adherence to biologic therapies and associated factors in rheumatoid arthritis, spondyloarthritis and psoriatic arthritis: a systematic literature review. Clin Exp Rheumatol 33:559–69.
   PubMed Web of Science ®Google Scholar
• Lyseng-Williamson KA. (2017). Certolizumab pegol administration devices: a profile of their use and usability. Drugs Ther Perspect 33:515–22.
   Google Scholar
• Makwana S, Basu B, Makasana Y, et al. (2011). Prefilled syringes: an innovation in parenteral packaging. Int J Pharm Investig 1:200–6.
   PubMedGoogle Scholar
• Mangham LJ, Hanson K, McPake B. (2009). How to do (or not to do) … Designing a discrete choice experiment for application in a low-income country. Health Policy and Planning 24:151–8.
   PubMed Web of Science ®Google Scholar
• Maniadakis N, Toth E, Schiff M, et al. (2018). A targeted literature review examining biologic therapy compliance and persistence in chronic inflammatory diseases to identify the associated unmet needs, driving factors, and consequences. Adv Ther 35:1333–55.
   PubMed Web of Science ®Google Scholar
• Mansoor SM, Krass I, Aslani P. (2013). Multiprofessional interventions to improve patient adherence to cardiovascular medications. J Cardiovasc Pharmacol Ther 18:19–30.
   PubMed Web of Science ®Google Scholar
• Marshall JK, Bessette L, Thorne C, et al. (2018). Impact of the adalimumab patient support program's care coach calls on persistence and adherence in Canada: an observational retrospective cohort study. Clinical Therapeutics 40:415–29.e6.
   PubMed Web of Science ®Google Scholar
• Maruotti N, Cantatore FP. (2014). Impact of biological therapy on spondyloarthritis. Eur J Clin Pharmacol 70:1021–7.
   PubMed Web of Science ®Google Scholar
• Matcham F, Norton S, Scott DL, et al. (2016). Symptoms of depression and anxiety predict treatment response and long-term physical health outcomes in rheumatoid arthritis: secondary analysis of a randomized controlled trial. Rheumatology (Oxford) 55:268–78.
   PubMed Web of Science ®Google Scholar
• McAllister L, Anderson J, Werth K, et al. (2014). Needle-free jet injection for administration of influenza vaccine: a randomised non-inferiority trial. Lancet 384:674–81.
   PubMed Web of Science ®Google Scholar
• Mease PJ. (2015). Biologic therapy for psoriatic arthritis. Rheum Dis Clin North Am 41:723–38.
   PubMed Web of Science ®Google Scholar
• MHRA, (2017). Human factors and usability engineering – guidance for medical devices including drug-device combination products. London, UK: MHRA.
   Google Scholar
• Michetti P, Weinman J, Mrowietz U, et al. (2017). Impact of Treatment-Related Beliefs on Medication Adherence in Immune-Mediated Inflammatory Diseases: Results of the Global ALIGN Study. Adv Ther 34:91–108.
   PubMed Web of Science ®Google Scholar
• Morgan C, McBeth J, Cordingley L, et al. (2015). The influence of behavioural and psychological factors on medication adherence over time in rheumatoid arthritis patients: a study in the biologics era. Rheumatology (Oxford) 54:1780–91.
   PubMed Web of Science ®Google Scholar
• Mougiakakou SG, Bartsocas CS, Bozas E, et al. (2010). SMARTDIAB: a communication and information technology approach for the intelligent monitoring, management and follow-up of type 1 diabetes patients. IEEE Trans Inform Technol Biomed 14:622–33.
   PubMedGoogle Scholar
• Muller-Ladner U, Flipo RM, Vincendon P, et al. (2012). Comparison of patient satisfaction with two different etanercept delivery systems. A randomised controlled study in patients with rheumatoid arthritis. Z Rheumatol 71:890–9.
   PubMed Web of Science ®Google Scholar
• Nafradi L, Nakamoto K, Schulz PJ. (2017). Is patient empowerment the key to promote adherence? A systematic review of the relationship between self-efficacy, health locus of control and medication adherence. PLoS One 12:e0186458.
   PubMed Web of Science ®Google Scholar
• Panescu D. (2009). Medical device development. Conf Proc IEEE Eng Med Biol Soc 2009:5591–4.
   PubMedGoogle Scholar
• Pasma A, Schenk CV, Timman R, et al. (2015). Non-adherence to disease-modifying antirheumatic drugs is associated with higher disease activity in early arthritis patients in the first year of the disease. Arthritis Res Ther 17:281.
   PubMed Web of Science ®Google Scholar
• Pasma A, van't Spijker A, Hazes JM, et al. (2013). Factors associated with adherence to pharmaceutical treatment for rheumatoid arthritis patients: a systematic review. Semin Arthritis Rheum 43:18–28.
   PubMed Web of Science ®Google Scholar
• Patel S, Jacobus-Kantor L, Marshall L, et al. (2013). Mobilizing your medications: an automated medication reminder application for mobile phones and hypertension medication adherence in a high-risk urban population. J Diabetes Sci Technol 7:630–9.
   PubMedGoogle Scholar
• Phillips LA, Diefenbach MA, Kronish IM, et al. (2014). The necessity-concerns framework: a multidimensional theory benefits from multidimensional analysis. Ann Behav Med 48:7–16.
   PubMed Web of Science ®Google Scholar
• Quante M, Thate-Waschke I, Schofer M. (2012). What are the reasons for patient preference? A comparison between oral and subcutaneous administration. Z Orthop Unfall 150:397–403.
   PubMed Web of Science ®Google Scholar
• Renzi C, Picardi A, Abeni D, et al. (2002). Association of dissatisfaction with care and psychiatric morbidity with poor treatment compliance. Arch Dermatol 138:337–42.
   PubMed Web of Science ®Google Scholar
• Rubin DT, Mittal M, Davis M, et al. (2017). Impact of a patient support program on patient adherence to adalimumab and direct medical costs in Crohn's disease, ulcerative colitis, rheumatoid athritis, psoriasis, psoriatic arthritis, and ankylosing spondylitis. J Manag Care Spec Pharm 23:859–67.
   Google Scholar
• Saini SD, Schoenfeld P, Kaulback K, et al. (2009). Effect of medication dosing frequency on adherence in chronic diseases. Am J Manag Care 15:e22–33.
   PubMed Web of Science ®Google Scholar
• Salmon P, Hall GM. (2003). Patient empowerment and control: a psychological discourse in the service of medicine. Soc Sci Med 57:1969–80.
   PubMed Web of Science ®Google Scholar
• Schiff M, Koo J, Jin E, et al. (2016). Usability and acceptability of the abatacept pre-filled autoinjector for the subcutaneous treatment of rheumatoid arthritis. Adv Ther 33:199–213.
   PubMed Web of Science ®Google Scholar
• Schiff M, Saunderson S, Mountian I, et al. (2017). Chronic disease and self-injection: ethnographic investigations into the patient experience during treatment. Rheumatol Ther 4:445–63.
   PubMed Web of Science ®Google Scholar
• Schulze-Koops H, Giacomelli R, Samborski W, et al. (2015). Factors influencing the patient evaluation of injection experience with the SmartJect autoinjector in rheumatoid arthritis. Clin Exp Rheumatol 33:201–8.
   PubMed Web of Science ®Google Scholar
• Schwartzman S, Morgan GJ. Jr. (2004). Does route of administration affect the outcome of TNF antagonist therapy? Arthritis Res Ther 6:S19–S23.
   PubMed Web of Science ®Google Scholar
• Sheikhzadeh A, Yoon J, Formosa D, et al. (2012). The effect of a new syringe design on the ability of rheumatoid arthritis patients to inject a biological medication. Appl Ergon 43:368–75.
   PubMed Web of Science ®Google Scholar
• Sivamani RK, Goodarzi H, Garcia MS, et al. (2013). Biologic therapies in the treatment of psoriasis: a comprehensive evidence-based basic science and clinical review and a practical guide to tuberculosis monitoring. Clinic Rev Allergy Immunol 44:121–40.
   Google Scholar
• Thomson R, Martin JL, Sharples S. (2013). The psychosocial impact of home use medical devices on the lives of older people: a qualitative study. BMC Health Serv Res 13:467.
   PubMed Web of Science ®Google Scholar
• Trivedi I, Hanauer SB. (2015). Balancing the risks and benefits of biologic therapy in inflammatory bowel diseases. Expert Opin Drug Saf 14:1915–34.
   PubMed Web of Science ®Google Scholar
• van den Bemt BJ, van Lankveld WG. (2007). How can we improve adherence to therapy by patients with rheumatoid arthritis? Nat Clin Pract Rheumatol 3:681.
   PubMedGoogle Scholar
• Van den Bosch F, Wassenberg S, Östör A, et al. (2017). Impact of patient support program utilization on patient activation measure scores among patients with rheumatoid arthritis [abstract]. Arthritis Rheumatol 69. https://acrabstracts.org/abstract/impact-of-patient-support-program-utilization-on-patient-activation-measure-scores-among-patients-with-rheumatoid-arthritis/
   Google Scholar
• Vangeli E, Bakhshi S, Baker A, et al. (2015). A systematic review of factors associated with non-adherence to treatment for immune-mediated inflammatory diseases. Adv Ther 32:983–1028.
   PubMed Web of Science ®Google Scholar
• Vermeire S, D'Heygere F, Nakad A, et al. (2018). Preference for a prefilled syringe or an auto-injection device for delivering golimumab in patients with moderate-to-severe ulcerative colitis: a randomized crossover study. Patient Prefer Adherence 12:1193–202.
   Google Scholar
• Wang D, Li Y, Liu Y, et al. (2014). The use of biologic therapies in the treatment of rheumatoid arthritis. Curr Pharm Biotechnol 15:542–8.
   PubMed Web of Science ®Google Scholar